Cargando…
Addressing the affordability of cancer drugs: using deliberative public engagement to inform health policy
BACKGROUND: Health system expenditure on cancer drugs is rising rapidly in many OECD countries given the costly new treatments and increased rates of use due to a growing and ageing population. These factors put considerable strain on the sustainability of health systems worldwide, sparking public d...
Autores principales: | Bentley, Colene, Peacock, Stuart, Abelson, Julia, Burgess, Michael M., Demers-Payette, Olivier, Longstaff, Holly, Tripp, Laura, Lavis, John N., Wilson, Michael G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367823/ https://www.ncbi.nlm.nih.gov/pubmed/30732616 http://dx.doi.org/10.1186/s12961-019-0411-8 |
Ejemplares similares
-
Trade-offs, fairness, and funding for cancer drugs: key findings from a deliberative public engagement event in British Columbia, Canada
por: Bentley, Colene, et al.
Publicado: (2018) -
Public perspectives on disinvestments in drug funding: results from a Canadian deliberative public engagement event on cancer drugs
por: Costa, Sarah, et al.
Publicado: (2019) -
Sharing linked data sets for research: results from a deliberative public engagement event in British Columbia, Canada
por: Teng, Jack, et al.
Publicado: (2019) -
Evaluating deliberative dialogues focussed on healthy public policy
por: Lavis, John N, et al.
Publicado: (2014) -
Sequencing the salmon genome: A deliberative public engagement
por: O'Doherty, Kieran, et al.
Publicado: (2010)